Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 26,695 | 45,035 | 25,511 | 14,537 | 6,640 |
| Operating Income | -26,695 | -45,035 | -25,511 | -14,537 | -6,640 |
| Other Income | 2,105 | -11,169 | 183 | 50 | 1,178 |
| Pre-tax Income | -24,590 | -56,204 | -25,329 | -14,487 | -5,462 |
| Net Income Continuous | -24,590 | -56,204 | -25,329 | -14,487 | -5,462 |
| Net Income | $-24,590 | $-56,204 | $-25,329 | $-14,487 | $-5,462 |
| EPS Basic Total Ops | -2.02 | -6.23 | -3.10 | -1.90 | -0.87 |
| EPS Basic Continuous Ops | -2.02 | -6.23 | -3.10 | -1.90 | -0.87 |
| EPS Diluted Total Ops | -2.31 | -6.23 | -3.10 | -1.90 | -0.87 |
| EPS Diluted Continuous Ops | -2.01 | -6.23 | -3.10 | -1.90 | -0.87 |
| EPS Diluted Before Non-Recurring Items | -2.31 | -4.92 | -3.10 | -1.90 | -0.87 |
| EBITDA(a) | $-26,695 | $-45,035 | $-25,511 | $-14,537 | $-6,640 |